STOCK TITAN

CNO insider sale notice: 4,862 shares via Morgan Stanley, prior 6,420-share sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for proposed sale of CNO Financial Group, Inc. securities. The filing shows an intended sale of 4,862 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $184,655.84 and 96,931,934 shares outstanding. The approximate date of sale is listed as 08/14/2025 on the NYSE.

The filer reports acquisition details: 1,478 performance shares acquired 02/15/2024 and 3,384 restricted shares acquired 08/09/2024, both from the issuer. The filing also discloses sales during the past three months by Jeanne Linnenbringer totaling 6,420 common shares sold on 08/13/2025 with gross proceeds of $167,782.76 and $75,919.80.

Certain filer and issuer identifying fields (CIK, issuer name, contact details) are not populated in the provided text.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider notice showing sale of 4,862 CNO shares and recent prior sales by the same holder; no new operational data.

The Form 144 documents a proposed brokerage sale of 4,862 common shares via Morgan Stanley and itemizes the acquisition dates and types for those shares (performance shares and restricted stock acquired in 2024). It also records two prior sales on 08/13/2025 by Jeanne Linnenbringer totaling 6,420 shares with stated gross proceeds. This filing is procedural under Rule 144 and does not include financial performance, forward guidance, or disclosures about issuer operations. Impact is informational for transaction timing and size only.

TL;DR: Disclosure is a standard compliance filing showing insider sales; missing issuer and filer identifiers limit traceability.

The record provides necessary Rule 144 details about the class, broker, quantities, acquisition origin (issuer), and dates, fulfilling transaction disclosure requirements. However, several identifying fields (issuer name, filer CIK/contact) are absent in the provided content, which constrains verification and investor due diligence. The filing includes the required attestation language about lack of material nonpublic information.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Cno Finl Group Inc

NYSE:CNO

CNO Rankings

CNO Latest News

CNO Latest SEC Filings

CNO Stock Data

4.02B
92.29M
Insurance - Life
Accident & Health Insurance
Link
United States
CARMEL